ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

38,893Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 5176

$3.37M Total Retail Price of All Prescriptions

Rank: 7 out of 5176

999 Patients Receiving at Least One Drug in Part D
96%Patients 65 Years and Older
91% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

2% of this provider’s 38,157 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

52% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$87 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

39 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
EVISTA 2,306 2,260 10 1 65
AMLODIPINE BESYLATE 2,116 2,110 2 2
SIMVASTATIN 2,004 1,953 3 1
LIDODERM 1,072 1,053 4 59
NEXIUM 1,057 1,039 5 16
METOPROLOL SUCCINATE 1,046 1,034 6 11
OMEPRAZOLE 835 815 7 3
LOSARTAN POTASSIUM 828 808 8 14
CRESTOR 762 731 9 15
DIOVAN 725 696 10 19
METFORMIN HCL 677 660 11 7
CLOBETASOL PROPIONATE 648 646 12 130
COLCRYS 608 585 10 13 170
ALENDRONATE SODIUM 566 531 14 18
CELEBREX 562 561 15 80
BISOPROLOL-HYDROCHLOROTHIAZIDE 556 552 16 164
TAMSULOSIN HCL 541 540 17 20
ATORVASTATIN CALCIUM 518 508 18 9
CLOPIDOGREL 494 493 19 26
PLAVIX 460 460 20 29
GLIMEPIRIDE 460 445 20 37
LISINOPRIL 446 434 22 5
MECLIZINE HCL 445 442 23 81
AMMONIUM LACTATE 441 441 24 91
DIOVAN HCT 402 402 25 39
AVODART 380 379 26 107
FAMOTIDINE 365 364 27 58
SPIRIVA 353 348 28 54
ACARBOSE 347 333 10 29 223
AZITHROMYCIN 344 324 30 42
DONEPEZIL HCL 341 341 31 28
BENICAR 327 323 32 100
ALLOPURINOL 309 304 33 41
PROMETHAZINE HCL 301 283 R 34 221
MELOXICAM 299 289 35 53
ATENOLOL 299 299 35 12
LOSARTAN-HYDROCHLOROTHIAZIDE 285 274 37 35
ADVAIR DISKUS 283 267 38 32
PRAVASTATIN SODIUM 261 258 39 23
JANUVIA 249 244 40 25
JANUMET 247 237 41 77
CARVEDILOL 245 230 42 24
LEVOTHYROXINE SODIUM 238 237 43 4
GABAPENTIN 234 227 44 21
GLYBURIDE-METFORMIN HCL 231 210 R 45 76
SINGULAIR 230 230 46 62
VOLTAREN 229 229 47 97
METFORMIN HCL ER 228 220 48 57
AMLODIPINE BESYLATE-BENAZEPRIL 212 212 49 55
PATANOL 194 193 50 158
BYSTOLIC 189 189 51 96
ONGLYZA 174 171 52 153
PROAIR HFA 169 168 53 60
TRIAMCINOLONE ACETONIDE 166 163 54 125
FUROSEMIDE 162 162 55 8
DILTIAZEM 24HR CD 160 160 56 119
ISOSORBIDE MONONITRATE ER 157 155 57 44
FINASTERIDE 157 157 57 69
BENICAR HCT 153 153 59 110
DIGOXIN 152 152 60 56
SERTRALINE HCL 151 151 61 30
POTASSIUM CHLORIDE 150 150 62 34
FLUTICASONE PROPIONATE 143 137 63 38
EXFORGE 141 141 64 126
AGGRENOX 141 141 64 235
LIDOCAINE 139 137 66 179
SINGLE USE SWAB 138 136 67 108
AMOX TR-POTASSIUM CLAVULANATE 137 131 68 141
SYMBICORT 136 133 69 120
DOXAZOSIN MESYLATE 134 134 70 103
MICARDIS 134 134 70 154
NIASPAN 128 128 72 175
ACTONEL 127 127 73 134
PROCTOZONE-HC 127 126 73 171
METOPROLOL TARTRATE 127 122 73 6
NAMENDA 124 124 76 47
WARFARIN SODIUM 123 123 77 13
LIPITOR 118 118 78 51
ACTOS 117 117 79 85
LISINOPRIL-HYDROCHLOROTHIAZIDE 114 114 80 49
SOLARAZE 113 113 81 157
MONTELUKAST SODIUM 113 113 81 123
CIPROFLOXACIN HCL 111 107 83 84
HYDROXYZINE HCL 110 109 R 84 213
POLYETHYLENE GLYCOL 3350 108 108 85 74
RANITIDINE HCL 107 107 86 36
NIFEDIPINE ER 103 103 87 48
AMPICILLIN TRIHYDRATE 101 100 88 504
RIVASTIGMINE 99 99 89 364
NASONEX 94 93 90 178
ECONAZOLE NITRATE 93 92 91 340
TRILIPIX 88 88 92 187
FENOFIBRATE 87 72 93 102
MOMETASONE FUROATE 85 83 94 251
TRICOR 82 82 95 148
CLOTRIMAZOLE-BETAMETHASONE 82 81 95 94
VESICARE 80 80 97 210
GLIPIZIDE XL 78 69 98 83
TRIAMTERENE-HCTZ 77 76 99 86
SYNTHROID 77 77 99 33
OXYBUTYNIN CHLORIDE ER 76 76 101 204
BENAZEPRIL HCL 75 75 102 131
VALSARTAN-HYDROCHLOROTHIAZIDE 75 72 102 292
CICLOPIROX 72 72 104 279
MICARDIS HCT 70 70 105 180
ZETIA 68 68 106 68
BETAMETHASONE DIPROPIONATE 68 67 106 260
BARACLUDE 64 61 108 373
ALBUTEROL SULFATE 63 63 109 99
OLANZAPINE 62 61 110 140
LABETALOL HCL 62 62 110 114
KOMBIGLYZE XR 62 62 110 291
FLOVENT HFA 61 61 113 203
GEMFIBROZIL 61 61 113 139
CARBIDOPA-LEVODOPA 60 60 115 98
ZOLPIDEM TARTRATE 59 58 116 17
FLUOCINONIDE 59 58 116 165
LOPERAMIDE 57 57 118 329
LOVAZA 57 51 118 43
SUCRALFATE 56 56 120 303
CITALOPRAM HBR 56 56 120 31
PROPRANOLOL HCL 56 53 120 199
AZOR 55 49 123 194
BACTROBAN 54 54 124 462
NYSTATIN-TRIAMCINOLONE 54 54 124 142
IBANDRONATE SODIUM 54 54 124 211
PIOGLITAZONE HCL 53 52 R 127 237
BACLOFEN 53 52 127 173
CEFUROXIME 50 46 129 273
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.